Skip to main content

third-rock-ventures-logo

Biotech venture capital is supposed to be the highest-risk/highest-reward type of investment there is. But many biotech VCs are actually pretty conservative, hesitant to wager on edgy science that might take a decade to pay off.

{iframe}http://www.forbes.com/sites/luketimmerman/2016/10/31/third-rock-ventures-one-of-biotechs-daring-investors-raises-616m-for-more-startups/#214e0fdaf56d{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.